China Healthcare Sector Report 2021 3rd QuarterAn EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company Date: November 2021
Available in: English
As the global epidemic is being contained and China’s economic growth has returned to normal, the growth of the country's healthcare sector is likely to gradually slow down to pre-pandemic levels. In the second quarter of 2021, the government’s spending on health and family planning in China declined by 0.6% y/y to RMB 506.6bn. However, residents' expenditures on medicine and medical services are expected to retain a steady growth. In Q2 2021, the per capita healthcare expenditures of urban residents reached RMB 634, up by 22.4% y/y, while those of rural residents was RMB 396, up by 24.1% y/y. This was a combined result of sector reforms, accelerated application of online health services, and the ongoing push for private supply of healthcare services.
This report provides a complete and detailed analysis of the healthcare sector for China. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
- Understand the key elements at play in the healthcare sector in China
- Access forecasts for growth in the sector
- View key data on healthcare spending and health insurance in China
- Crystallise the forces both driving and restraining this sector in China
- Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
- Gain an understanding of the regulatory environment for the sector in China
- Build a clear picture of trends and issues for sub-sectors (e.g. medical institutions, medical devices and pharmaceuticals).
See below for a complete table of report contents: